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ABSTRAK
Post-infectious bronchiolitis obliterans adalah penyakit yang jarang berlaku. 
Ianya disebabkan oleh jangkitan saluran respiratori bawahan yang kerap, yang 
menyebabkan saluran pernafasan menjadi sempit secara kronik. Manakala, 
subpleural cysts ditemui hanya pada 20-36% pesakit sindrom Down. Kami 
melaporkan kes seorang kanak-kanak sindrom Down berumur 30 bulan yang 
mempunyai penemuan menarik pada radiograf HRCT toraks yang menunjukkan 
dua ciri iaitu bronchiolitis obliterans dan subpleural cysts. Pesakit yang dilahirkan 
pramatang ini menghidapi jangkitan paru-paru selepas lahir dan kemudiannya 
mendapat tiga lagi episod jangkitan paru-paru pada umur 18, 19 dan 26 bulan. 
Beliau mempunyai gejala batuk yang kronik, pernafasan laju dan berbunyi. Pada 
pemeriksaan fizikal, terdapat tanda-tanda yang menunjukkan masalah saluran 
pernafasan tersekat yang kronik. Sampel kahak dari nasofarinks didapati positif 
virus Influenza B. Setakat pengetahuan kami, ini merupakan laporan pertama 
tentang kewujudan kedua-dua entiti radiologi tersebut pada seorang kanak-kanak 
sindrom Down.
Kata kunci: bronchiolitis obliterans, sindrom Down, subpleural cysts
ABSTRACT
Post-infectious bronchiolitis obliterans is a rare disease that may occur following 
a microbiological insult towards the lower respiratory tract causing a severe form 
of chronic obstructive airway disease. Subpleural lung cyst may occur in 20-36% 
of Down syndrome. We report a case of a 30-month-old Down syndrome child 
who had interesting radiological concurrent findings of bronchiolitis obliterans 
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with subpleural cysts on High Resolution Computed Tomography (HRCT) thorax. 
This patient was born premature and had early onset pneumonia during the 
neonatal period. Subsequently, he had three episodes of pneumonias at 18, 19 
and 26 months. He presented with recurrent symptoms of cough, wheeze, rapid 
breathing and had features of persistent airway obstruction characterized by 
chest hyperinflation, persistent tachypnoea with crepitations and rhonchi despite 
on regular bronchodilators. The only positive culture was Influenza B from his 
nasopharyneal aspirate culture. To our knowledge, this is the first reported case 
with both radiological entities in a child with Down syndrome.  
Keywords: bronchiolitis obliterans, Down syndrome, subpleural cyst
 Respiratory infection is one of 
the most common reasons for 
hospitalization in children with Down 
syndrome. However, the available 
reports on pulmonary involvement in 
this group are limited (Yang et al. 2002; 
Gonzales et al. 1991; Joshi et al. 1986; 
Tyrrell et al. 1999; George et al. 2016; 
Biko et al. 2008). We wish to highlight 
the first reported case of a child with 
Down syndrome who had interesting 
radiological concurrent findings of 
bronchiolitis obliterans and diffuse 
subpleural cysts following recurrent 
pneumonias.
CASE REPORT
A 30-month-old boy with Down 
syndrome was born premature at 
32 weeks with birth weight of 1.31 
kg. He had early onset pneumonia 
required non-invasive ventilation and 
supplemental oxygen support for 18 
days in neonatal intensive care unit. 
He had patent ductus arteriosus which 
was spontaneously closed at day 10 of 
life. 
 Subsequently, he had recurrent 
INTRODUCTION
Down syndrome is the most common 
cause of chromosomal abnormalities 
in children (Thillainathan et al. 2014). 
They are characterised by having 
distinctive dysmorphic features of 
the head and neck with upslanting 
palpebral fissures, epicanthic folds, 
brachycephaly, Brushfield spots of 
the eyes, protruding tongue and 
excessive skin at the nape of the neck. 
The extremities features include short 
broad hands, single palmar crease, 
clinodactyly, widened sandal gap and 
hyperflexibility of the joints (Jones 
2006; Epstein 2001).
 The condition is also associated 
with several health conditions such as 
congenital heart disease (Benhaourech 
et al. 2016), congenital airway anomaly 
(Bertrand et al. 2003), genitourinary 
abnormalities (Faizah et al. 2011) and 
childhood leukaemia (Nurasyikin et 
al. 2012). The management involves 
a holistic approach and continuous 
evaluation to monitor for probable 
complications and disorders that are 
associated with this condition.
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admissions for pneumonias at 18, 19 
and 26 months when he presented 
with recurrent symptoms of fever, 
cough and rapid breathing. During 
the first two admissions, he required 
supplemental oxygen, received a 
course of intravenous antibiotics and 
regular nebulised salbutamol for four 
to five days. Nasopharyngeal aspirate 
culture was positive for Influenza 
B in the second admission and he 
received a course of oseltamivir. In 
between admissions, there was history 
of intermittent chesty cough especially 
upon exertion. He was then started 
on inhaled steroid i.e. metered dose 
inhaler (MDI) fluticasone during his 
second admission.
 Seven months later, he was 
readmitted with high grade fever 
associated with severe respiratory 
distress. Clinical examination revealed 
increased anteroposterior diameter 
of the chest, tachypnoea, right sided 
crepitations and generalised rhonchi. 
Chest X-ray (Figure 1) showed 
bilateral interstitial opacities and focal 
consolidation at right hilar region with 
minimal pleural effusion. He received 
supplemental oxygen for 1 week. 
Intravenous penicillin was commenced 
but later changed to intravenous 
cefuroxime and oral azithromycin was 
also added due to persistent fever. 
He also received regular nebulised 
salbutamol. He responded to treatment 
and was discharged after 2 weeks.
Figure 1: Anteroposterior chest radiograph done 
when he presented with acute pneumonia. 
There is bilateral interstitial opacities associated 
with focal consolidation at right  hilar region (*). 
Bilateral minimal pleural effusion is also noted 
(white arrow)
Figure 2: Lung window of CT thorax shows (A: axial & B: sagittal) multiple air-filled cavities located 
at subpleural regions (black arrows) as well as along the major fissure (white arrow) (C: axial). There 
are also geographical areas of lucency in between the relatively denser normal lung parenchyma 
represents bronchiolitis obliterans (*). HRCT thorax showed features of bronchiolitis obliterans and 
diffuse subpleural cyts
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 In view of persistent lung findings, 
high resolution computed tomography 
(HRCT) thorax (Figure 2) was then 
performed which showed features of 
bronchiolitis obliterans with diffuse 
subpleural cysts.
 Subsequently on follow up, he was 
well apart from having 1 episode of 
mild upper respiratory tract infection 
requiring oral antibiotics and needed 
infrequent use of MDI salbutamol. MDI 
fluticasone was then discontinued.
DISCUSSION
Diffuse parenchymal diseases among 
Down syndrome can develop as 
a primary process which includes 
pulmonary hypoplasia, pulmonary 
lymphangiectasia and interstitial 
lung diseases or due to secondary 
aetiologies such as post-infectious 
complications, cardiac and pulmonary 
vascular diseases and chronic 
aspiration. Children with Down 
syndrome are at an increased risk of 
respiratory infections compared to 
children without Down syndrome, 
to have a severe cause or even death 
due to respiratory causes (Hilton et al. 
1999). A study in Netherlands showed 
that 53% of admissions among 
children with Down syndrome are due 
to lung infections (van Trotsenburg et 
al. 2006).
 Post-infectious bronchiolitis 
obliterans is a rare disease that may 
occur following a microbiological 
insult towards the lower respiratory 
tract, causing a severe form of 
chronic obstructive airway disease. 
Pathologically, it is characterized 
by a fibrosing inflammatory process 
surrounding the bronchioles causing 
concentric obliteration and obliteration 
of small airways (Kurland & Michelson 
2005). Common aetiological agents 
include adenovirus, Mycoplasma 
pneumoniae, influenza, parainfluenza 
and respiratory syncytial virus (Kim 
et al. 2001). This patient developed 
bronchiolitis obliterans following 
recurrent chest infections and the only 
organism isolated was Influenza B 
virus. 
 The diagnosis of bronchiolitis 
obliterans in this patient was made 
based on his typical presentation of 
persistent cough, dyspnoea, wheeze 
and crackles, indicating chronic 
obstructive airway disease and 
characteristic features on HRCT thorax 
i.e. mosaic pattern representing areas 
of air-trapping. Interestingly, he also 
had concurrent features of diffuse cysts 
at the subpleural region and along the 
major lung fissures. 
 Management of bronchiolitis 
obliterans requires a multidisciplinary 
approach with care at expert centres. 
The discussion of the treatment of 
post-infectious bronchiolitis is limited 
compared to those of bronchiolitis 
obliterans post-lung or bone marrow 
transplantation. Although the prognosis 
of post-infectious bronchiolitis 
obliterans is often better compared to 
other types of bronchiolitis obliterans. 
However, the natural course of this 
condition is variable in each case 
and could not be expected certainly 
(Kavaluinaite & Aurora 2019). 
Treatment with bronchodilator shows 
partial or no reversibility of airway 
obstruction compared to asthma. 
This is due to the damage caused by 
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irreversible obstruction to the small 
airways (Zhao et al. 2017). The use 
inhaled and systemic costicosteroids 
was described to combat the ongoing 
inflammation and prevent airway 
fibrosis (Moonnumakal & Fan 2008). 
Another study suggested that a 
combination of azithromycin and oral 
prednisolone offers certain benefits in 
treating these patients (Li et al. 2014).
 The reported incidence of 
subpleural lung cysts in patients 
with Down syndrome was between 
20-36%. Pulmonary cysts occurred 
predominantly at peripheral areas, 
although some can appear at lung 
fissures and bronchovascular bundles 
(Gonzales et al. 1991; Biko et al. 
2008). The exact mechanism of cysts 
formation in this group is not known. 
However, several contributing factors 
were postulated. It was first reported 
in 1986 by Joshi et al. (1986) whereby 
they discovered numerous small 
subpleural cysts on autopsy in two 
infants with Down syndrome and 
congenital heart disease. Gonzalez 
et al. (1991) in their autopsy review of 
98 patients with Down syndrome also 
found that congenital heart disease 
was frequently associated with lung 
cysts. Co-existence of congenital 
heart disease is associated with greater 
occurrence of the cysts (20%) compared 
to no congenital heart disease (4.3%) 
(Tyrrell et al. 1999; George et al. 2016). 
The most common congenital heart 
disease in this group is endocardial 
cushion defect. However, there was 
no significant evidence to suggest 
any specific type of cardiac disease 
contribute to the development of 
lung cysts among them. Patent ductus 
arterious may be a contributing factor 
in this patient. This condition was also 
reported in previous series of patients 
with Down syndrome with lung cysts 
before, but no definite association 
can be made due to small number of 
patients in the study (Biko et al. 2008)
 The cysts are less likely to be of 
congenital origin as previous autopsy 
reports of stillborn babies or fetuses 
with Down syndrome revealed no 
associated subpleural cysts (Joshi 
et al. 1986). Moreover, the airway 
and alveolar development continues 
into early postnatal life for in which 
contradicts to congenitally existence of 
cysts at the subpleural area. 
 Pulmonary hypoplasia might also 
be related to its development. Children 
with Down syndrome are found to 
have hypoplastic lung. There were 
diminished number of alveoli, a smaller 
alveolar surface area, and enlarged 
alveolar and alveolar ducts (Cooney 
& Thurlbeck 1982). As postulated from 
previous study, this may result in the 
formation of cystic dilatation of the 
alveoli as a compensatory mechanism 
(Joshi et al. 1986). As children with 
Down syndrome are often born with 
low birth weight, (Rasmussen et al. 
2006) we believe that this contributes 
to the atypical development of the 
lungs thus eventually causing cysts 
formation as this patient was born 
premature with birth weight on the 2nd 
centile for his gestational age.   
 In patients with bronchiolitis 
obliterans, there is an increased risk 
of pneumothorax (Wang et al. 2015; 
Kurland & Michelson 2005). In the 
presence of concurrent subpleural 
lung cysts, it is not known if there will 
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be a higher risk for pneumothorax.
CONCLUSION
Clinicians should be aware that 
respiratory infections are common in 
patients with Down syndrome and 
those with recurrent pneumonias 
may lead to bronchiolitis obliterans. 
Subpleural lung cyst is a known 
occurrence among patients with Down 
syndrome. In patients with persistent 
respiratory signs and symptoms, further 
imaging i.e. HRCT thorax is required to 
establish the diagnosis of both entities.
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